Abstract

Conduction abnormalities requiring permanent pacemaker (PPM) are a frequent complication following TAVR. Few studies have evaluated chronic pacemaker dependency after TAVR. To evaluate post-TAVR pacemaker dependency and impact on mortality at one year. 626 patients with severe aortic stenosis who underwent TAVR between 01/01/2012 and 12/31/2019 were identified. Those with pre-TAVR pacemaker were excluded. Patients underwent post TAVR PPM if found to have high grade AV block,> 5seconds pause or symptomatic bradycardia < 50 bpm. Patients who underwent TAVR without PPM implant represented the control arm. PPM dependency was defined as > 50% pacing during 1 and 30 days post implantation. All-cause mortality was reported at one year. Of 357 patients, 16% required PPM with no difference in either balloon expandable or self-expandable valve types (14.6% vs 17.6%; P=0.471). The mean age was 80 + 8.2 years, and 52.7% were male. The median time to PPM implantation was 2 days. The main indications were complete AV block (67%) and symptomatic bradycardia (8.8%). 56.1% received a dual chamber, 24.6% a single chamber and 8.8% received a biventricular PPM. At day 1 and 30 days following implant 73.7% and 78.9% of patient fulfilled criteria for PPM dependency. There were no difference in mortality between the cohorts at one year (Fig. 1). 78% of patients requiring PPM post TAVR were pace dependent at 30 days. PPM implantation did not have an impact on mortality at 1 year. Indications for acute pacing predicted PPM dependency at 30 days and support the selection criteria used for PPM implantation in this cohort.

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call